| Factor Information | |
|---|---|
| Data ID | 3696 |
| Factor | No. of postoperative arrhythmias |
| Description | The incidence of postoperative arrhythmias was lower in the study group: 8/65 in the study group and 17/66 in the control group, respectively (chi-squared test, P=0.05). |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To check the hypothesis that continuous magnesium infusion protects the heart from arrhythmias following cardiopulmonary bypass surgery for congenital heart disease. |
| p Value | 0.05 |
| Conclusion | Continuous magnesium infusion effectively reduces the rate of arrhythmias following cardiopulmonary bypass surgery for congenital heart disease and should, therefore, be routinely used. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 690 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | ASD/VSD/AVSD/LVOTO/AAO/SVES/EAT/AF/atrioventricular re-entry tachycardia/JET/VES/AV block |
| Reference | |
|---|---|
| PMID | 12774159 |
| Year | 2003 |
| Title | Randomised trial on the influence of continuous magnesium infusion on arrhythmias following cardiopulmonary bypass surgery for congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | serum | |
| Region | Berlin, Germany | |
| Method | Mann–Whitney U test for unpaired samples and the two-sided Pearson’s chi-squared test | |
| Race | European | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | the magnesium therapy group(Treatment) | the control group received placebo(Control) |
| Number | 8 (total: 65) | 17 (total: 66) |
| Age | 15±2 years | 14±2 years |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 0.123 | 0.258 |
